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Abstract
Treatment of periodontitis has beneficial effects on systemic inflammation markers that
relate to progression of atherosclerosis. We aimed to investigate whether immunization with
A hemagglutinin domain (Rgp44) of Porphyromonas gingivalis (Pg), a major etiologic agent
of periodontitis, would lead to an antibody response cross-reacting with oxidized low-density
lipoprotein (OxLDL) and how it would affect the progression of atherosclerosis in low-density
lipoprotein receptor-deficient (LDLR-/-) mice. The data revealed a prominent IgM but not IgG
response to malondialdehyde-acetaldehyde modified LDL (MAA-LDL) after Rgp44 and Pg
immunizations, implying that Rgp44/Pg and MAA adducts may share cross-reactive epi-
topes that prompt IgM antibody production and consequently confer atheroprotection. A sig-
nificant negative association was observed between atherosclerotic lesion and plasma IgA
to Rgp44 in Rgp44 immunized mice, supporting further the anti-atherogenic effect of Rgp44
immunization. Plasma IgA levels to Rgp44 and to Pg in both Rgp44- and Pg-immunized
mice were significantly higher than those in saline control, suggesting that IgA to Rgp44
could be a surrogate marker of immunization in Pg-immunized mice. Distinct antibody
responses in plasma IgA levels to MAA-LDL, to Pg lipopolysaccharides (Pg-LPS), and to
phosphocholine (PCho) were observed after Rgp44 and Pg immunizations, indicating that
different immunogenic components between Rpg44 and Pg may behave differently in
regard of their roles in the development of atherosclerosis. Immunization with Rgp44 also
displayed atheroprotective features in modulation of plaque size through association with
plasma levels of IL-1αwhereas whole Pg bacteria achieved through regulation of anti-
inflammatory cytokine levels of IL-5 and IL-10. The present study may contribute to refining
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inflammatory processes in atherosclerosis.
Introduction
Atherosclerosis plays a major role in cardiovascular disease (CVD) and is the leading cause of
death worldwide [1]. It is considered a chronic inflammatory disease [2] whose recognized
risk factors include environmental, genetic, and inflammatory elements [1]. Low-density lipo-
protein (LDL) particles circulate in the blood and can accumulate in the arterial intima leading
to the formation of arterial plaques [3]. Oxidative modification of LDL, which creates oxidized
LDL particles (OxLDL) and formation of malondialdehyde-modified LDL (MDA-LDL), is the
first step in the development of atherosclerosis. MDA is unstable and can further react with
acetaldehyde to form malondialdehyde acetaldehyde-modified LDL (MAA-LDL) [4–6]. MAA
adduct has been proposed to be one of the main epitopes for the immune system after MDA
modification of proteins or lipids in atherosclerosis [4,5,7]. Phosphocholine (PCho) is another
common epitope of oxidized phospholipids in OxLDL. It is also exposed on some microorgan-
isms, e.g. Streptococcus pneumoniae, and on apoptotic cells. A well characterized natural IgM
antibody, T15/EO6, binds both microbial antigens and stress-induced self-antigens, such as
OxLDL, via the recognition of PCho [8]. Active immunization with PCho and passive immu-
nization with anti-PCho ameliorate the development of atherosclerosis in apolipoprotein E-
null mice [9].
Periodontitis is known to associate with an increased risk of atherosclerosis. It is a chronic
inflammatory disease affecting tooth-supporting tissue, and a mild form of the disease is pres-
ent in the majority of adult population. Treatment of periodontitis improves systemic inflam-
mation markers that also relate to development of atherosclerosis [10,11]. Porphyromonas
gingivalis (Pg) is one of the most important bacterial species in chronic periodontitis [12]. Pg
can be detected in arterial plaques [13] and can also invade endothelial cells in human coro-
nary arteries [14]. Pg lipopolysaccharide (Pg-LPS) is the major component of the outer mem-
brane of the bacteria that stimulates the innate immune system and is a key virulence factor
that has been shown to induce production of cytokines [15]. LPS works through Toll-like
receptor 4 (TLR4). Pg has also been show to act through TLR2 engagement, and TLR2-me-
diated effects are reported to be important in alveolar bone loss in periodontal disease and ath-
erosclerosis [16,17]. Although the exact mechanisms linking periodontitis to atherosclerosis
are still not defined, the association between the two conditions is partially explained by previ-
ous studies [10].
Compelling evidence links inflammation and immune response to all phases of atheroscle-
rotic lesion development [18]. It has been suggested that IgM autoantibodies are atheroprotec-
tive whereas IgG autoantibodies are much more heterogeneous, but in general, they directly
correlate with CVD manifestations in univariate analyses [5,18–20]. Little information is avail-
able about the role of IgA in atherosclerosis. There appears to be an association between high
serum IgA titers and advanced vascular disease and myocardial infarction [18].
A mouse monoclonal IgM antibody (MDmAb) against MDA-LDL has previously been
cloned in our lab [21]. The antibody recognized gingipain protease produced by Pg and bound
to recombinant gingipain including a hemagglutinin/adhesin domain (Rgp44 domain, amino
acids 717–1135) [21]. We have also previously immunized mice with Pg bacteria, which led to
production of IgM antibodies to MDA-LDL and diminished atherosclerosis [22]. In this study,
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we aimed to investigate whether immunization with gingipain A hemagglutinin domain
(Rgp44) would induce antibody responses to malondialdehyde acetaldehyde (MAA) adducts
in mice. Plasma antibodies to OxLDL, aortic atherosclerotic lesions, and inflammatory/anti-
inflammatory cytokines were examined and the association among these biomarkers was
explored.
Materials and methods
Mice immunization and diets
The study was approved by the National Animal Experimental Board of Finland (ESAVI/
6097/04.10.03/2011). Forty female LDLR-/- mice (about 8 week-old) were randomly divided
into three immunization groups: adhesin/hemagglutinin domain of RgpA of Porphyromonas
gingivalis (Rgp44, n = 13), Porphyromonas gingivalis (Pg, n = 13), and phosphate buffered
saline (Saline, n = 14). The length of the study was 40 weeks, and procedures were carried out
as shown in S1 Fig. Mice were first injected subcutaneously with 50 μg protein, followed by
intraperitoneal booster injections of 25 μg of protein every 2 weeks for five boosters and every
month for six boosters. No adjuvants were used in the study. The mice were on chow diet
(4.4% fat and 0.2% cholesterol) for 13 weeks, followed by high-fat diet (HFD; 21.2% fat and
0.2% cholesterol, Western Diet TD88137 Harlan Tekland) for 27 weeks. Blood samples were
taken from the hind leg before immunizations and before HFD, and from the vena cava at the
time of sacrifice. Mouse aortas were collected for en face analysis after sacrifice.
Bacteria
Porphyromonas gingivalis (Pg), serotype ATCC 33277, was cultured on Brucella agar plates
supplemented with 5% horse blood, 100 mg/mL vitamin K1, and 5 μg/mL hemin anaerobically
at 37˚C for 6 days. Culture purity was determined by gram-staining and colony morphology.
Heat-inactivated Pg was made by incubation of bacteria suspension in PBS at 60˚C for 1 h and
frozen at -80˚C in small aliquots until further use.
Production of recombinant Rgp44 protein
Escherichia coli BL21(DE3)was used to express recombinant protein of Pg arginine-specific
gingipain A adhesion/hemagglutinin domain (Rgp44). The polymerase chain reaction amplifi-
cation and ligation of Rgp44 to pET32 Xa LIC vector were performed as described previously
[21]. ProBond Purification protocols were used with slight modification for the production of
histidine-tagged recombinant protein (Invitrogen, Carlsbad, CA, USA). E.coli cells were har-
vested by centrifugation at 4,500 × g for 15 min and native lysis buffer (50 mM Tris, 25 mM
sodium chloride, 2.5 mM magnesium chloride, and 0.1 mM calcium chloride, pH 8.0) was
used to suspend the cell pellets. Lysozyme was added to 1 mg/mL and the sample was incu-
bated at 30˚C for 50 min. Sonication was performed at 50% amplitude for 4 × 10 sec on ice.
DNase I (4 U/mL, Fermentas) was added and the sample was incubated at 37˚C for 15 min.
Cellular debris was collected by centrifugation at 4,500 × g for 15 min. Rgp44 recombinant
protein was mainly expressed in insoluble form and accumulated in the inclusion bodies.
Rgp44 was purified from E.coli inclusion bodies by adding denaturing lysis buffer (6 M guadi-
nium hydrochloride in native lysis buffer) for 10 min. The cell lysate was homogenized and
agitated gently for 20 min at +4˚C. The lysate was centrifuged at 100,000 × g for 30 min at
+4˚C. Soluble proteins in the supernatant were bound to nickel chelation slurry. Protein puri-
fication was done according to the ProBond Purification protocol. Purity of the histidine-
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tagged Rgp44 recombinant protein was analyzed by sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE).
LDL isolation and modifications
Low-density lipoprotein (LDL) fraction (density 1.019–1.063 g/mL) was isolated from mouse
plasma by sequential density gradient centrifugation [23]. Malondialdehyde acetaldehyde-
modified LDL (MAA-LDL) and copper-oxidized LDL (CuOx-LDL) were prepared as
described [21]. The extent of lipoprotein modification in each sample was verified by fluores-
cence measurements (excitation 355 nm, emission 460 nm) and colorimetric measurements
with 2,4,6-trinitrobenzene sulfonic acid [24].
Chemiluminescence immunoassay
The amount of antibodies was determined by chemiluminescence immunoassay as described
elsewhere [21]. Rgp44, heat-inactivated Pg, MAA-LDL, CuOx-LDL, phosphocholine-conjugated
bovine serum albumin (PCho-BSA, Biosearch Technologies, Novato, CA, USA), BSA, Pg-LPS
(Invivogen, San Diego, CA, USA) were used as antigens. The antigens were coated (5 μg/mL) in
phosphate-buffered saline (PBS) with 0.27 mmol/L ethylenediaminetetraacetic acid (EDTA) at
4˚C overnight onto white MicroFluor plates (Thermo Scientific, Rockford, IL, USA). The plates
were washed with PBS-EDTA three times using an automated plate washer and blocked with
PBS-EDTA containing 0.5% fish gelatin at room temperature for 1 h. Plasma samples were
diluted and measured in triplicate. Antibody binding was detected with an appropriate alkaline
phosphatase-labeled goat anti-mouse secondary antibody [Sigma-Aldrich, goat anti-mouse IgM
(μ-chain specific)-alkaline phosphatase, goat anti-mouse IgG (Fc specific)-alkaline phosphatase,
and goat anti-mouse IgA (α-chain specific)-alkaline phosphatase]. Chemiluminescence was
detected using LumiPhos530 substrate (Lumigen Inc. Southfield, MI, USA) with Wallac Victor3
multilabel reader, and expressed as relative light units (RLU) measured in 100 milliseconds (ms).
Determination of mouse atherosclerosis
Mouse atherosclerosis was analyzed using ‘en face’ analysis of whole aortas. After sacrifice,
blood was first collected from vena cava and mice were perfused with PBS containing 1 μg/mL
butylated hydroxytoluene (BHT) through the left ventricle for 10 min and perfusion-fixed
with 10% formalin, 5% sucrose, 20 μmol/L BHT and 3 μmol/L EDTA, pH 7.4 for 10 min. Aor-
tas were cleaned, stained with Sudan IV, and pinned onto paraffin plates. The images were
acquired with a Nikon D90 camera and Tokina AT-X 100 PRO D macro lens. Stained aortic
plaque areas were analyzed using ImageJ 1.48v analysis software (https://imagej.net/ImageJ)
and expressed as percentage of plaque area per total area of aorta.
Determination of plasma cytokines
Cytokines were measured using mouse Th1/Th2/Th17/Th22 13plex assay (eBioscience,
Vienna, Austria). A mixture of coated beads for each analyte to be measured was incubated
with 25 μL of undiluted plasma samples or standard mixture. The biotin-conjugated secondary
antibody mixture was added to bind to the analytes captured by the first antibodies. Finally,
Streptavidin-Phycoerythrin bound to the biotin conjugate leading to the emission of fluores-
cent signals. The samples were analyzed with FACSCalibur flow cytometer and CellQuest soft-
ware (BD Biosciences, San Jose, CA) and calculated by FlowCytomix Pro 3.0 Software. In
mouse Th1/Th2/Th17/Th22 Flowcytomix 13plex assay the standard range is 27–20,000 pg/mL
(IFN-γ, IL-1α, IL-2, IL-4, IL-5, IL-6, IL-10, IL-13, IL-17, IL-21 and TNF-α), 2.7–2,000 pg/mL
Immune response to Rgp44 and Pg in low-density lipoprotein receptor-deficient mice
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(IL-22) and 69–50,000 pg/mL (IL-27). The mean intra-assay coefficient of variation of three
independent assays with six replicates of four samples is less than 6.4% and the inter-assay
coefficient of variation less than 10.9% in all analyses.
Statistics
Statistical analyses were performed using IBM SPSS statistics version 22.0. Nonparametric
Mann-Whitney U test was used to detect differences between the variables in different treat-
ment groups and nonparametric Wilcoxon signed-rank test to analyze differences between the
variables within the same treatment groups. The associations were evaluated by Spearman’s
correlation coefficient (03C1).
Results
Prominent immune responses to Rgp44 and Pg bacteria
Female LDLR-/- mice (about 8 weeks old) were randomly divided into three immunization
groups (saline, Rgp44, and Pg). The experimental timeline is shown in S1 Fig. Recombinant
gingipain A hemagglutinin domain (Rgp44) and heat-inactivated whole Pg bacteria (Pg)
induced prominent immune responses in LDLR-/- mice. Plasma IgG and IgM (S2 Fig) anti-
body levels to both Rgp44 and Pg were significantly elevated in Rgp44- and Pg-immunized
mice when compared to the mice immunized with phosphate buffered saline (saline).
Plasma IgM antibody levels to MAA-LDL, CuOx-LDL, and PCho increased
significantly after Rgp44 and Pg immunizations
To investigate whether the immunizations induced the antibodies binding to oxidation-spe-
cific epitopes, plasma antibody levels against MAA-LDL, copper-oxidized LDL (CuOx-LDL),
and phosphocholine modified bovine serum albumin (PCho-BSA) were measured. Compared
to the control group, IgM antibodies to MAA-LDL (Fig 1) increased remarkably in both the
Rgp44 (p< 0.001) and Pg (p< 0.001) groups at the end of the study. IgM antibodies to CuOx-
LDL (Fig 2) increased significantly in the mice immunized with Rgp44 (p< 0.001) and Pg
(p< 0.001) showing no difference between the two immunizations. Substantial elevation of
IgM antibodies to PCho was also found in Rgp44- (p< 0.001) and Pg- (p< 0.001) immunized
mice when compared to controls (Fig 3).The IgM antibodies to PCho in the Rgp44 group were
even significantly higher than those of the Pg group (p = 0.023). Plasma IgG antibody levels to
MAA-LDL (Fig 1), CuOx-LDL (Fig 2), and PCho (Fig 3) did not increase and were similar in
all immunization groups during the study.
The IgA to OxLDL, PCho, and bacterial antigens were studied. Plasma IgA levels to
MAA-LDL were significantly elevated only in the Pg group (Fig 1). IgA levels to CuOx-LDL
remained similar in all immunization groups (Fig 2). Prominent plasma IgA responses to
Rgp44 (p< 0.001 in both Rgp44 and Pg immunizations) and to Pg bacteria (p< 0.05 in Rgp44
immunization and p< 0.001 in Pg immunization) were observed in both Rgp44- and Pg-
immunized mice (Fig 4). Plasma IgA antibody levels to PCho increased only in Rgp44-immu-
nized mice at the end of the study (Fig 4). Pg-immunized mice, but not Rgp44 or control mice,
had increased plasma IgA to Pg lipopolysaccharide (Pg-LPS) (Fig 4).
High plasma IgA levels to Rgp44 were associated with less atherosclerotic
lipid deposits in Rgp44-immunized mice
To investigate whether the immune responses to Rgp44 or Pg modulated the development of
atherosclerosis, atherosclerotic lipid deposition in aorta was stained with Sudan IV (S3 Fig).
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Fig 1. Mouse plasma antibody levels to MAA-LDL before immunization (week 0) and at the end of the study
(week 39) in LDLR-/- mice immunized with saline, Rgp44, and heat-inactivated Pg. Each mouse plasma sample was
measured in triplicate using chemiluminescence immunoassay. The antibody binding is expressed as mean ± SD in
relative light units measured in 100 milliseconds (RLU/100ms). Plasma antibody levels as box-whisker plots represent
25%, 50% and 75% of the distribution, where the whiskers represent 10% and 90% distribution of the values and the
cross represents the maximum and minimum range. The solid diamonds are the mean values. P-values less than 0.05
are regarded as statistically significant (nonparametric Mann-Whitney U test).  p< 0.05,  p< 0.01,  p< 0.001.
https://doi.org/10.1371/journal.pone.0191216.g001
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Fig 2. Mouse plasma antibody levels to CuOx-LDL before immunization (week 0) and at the end of the study
(week 39) in LDLR-/- mice immunized with saline, Rgp44, and heat-inactivated Pg. Each mouse plasma sample was
measured in triplicate using chemiluminescence immunoassay. The antibody binding is expressed as mean ± SD in
relative light units measured in 100 milliseconds (RLU/100ms). Plasma antibody levels as box-whisker plots represent
25%, 50% and 75% of the distribution, where the whiskers represent 10% and 90% distribution of the values and the
cross represents the maximum and minimum range. The solid diamonds are the mean values. P-values less than 0.05
are regarded as statistically significant (nonparametric Mann-Whitney U test).  p< 0.001.
https://doi.org/10.1371/journal.pone.0191216.g002
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The stained aortic plaque areas were measured and the results were expressed as percentage of
the plaque area per total area of aorta (en face analysis) (S3 Fig). The plaque size varied from
approximately 5 to 22% of the total aortic area. The mean values of the aortic lesion area were
12.89%, 10.86%, and 11.28% in the saline-, Rgp44- and Pg-immunized mice, respectively.
Although no significant differences were found between the three immunization groups, there
was less plaque area in Rgp44- and Pg-immunized mice (S3 Fig). More importantly,
Rgp44-immunized mice with high plasma IgA antibody levels to Rgp44 had less atheroscle-
rotic lipid deposits compared to those with low plasma IgA to Rgp44. There was a significant
negative association between the plaque area and plasma IgA levels to Rgp44 (ρ = - 0.713,
p = 0.009, Fig 5). In contrast, LDLR-/- mice immunized with the whole Pg bacteria having high
Fig 3. Mouse plasma antibody levels to PCho before immunization (week 0) and at the end of the study (week 39)
in LDLR-/- mice immunized with saline, Rgp44, and heat-inactivated Pg. Each mouse plasma sample was measured
in triplicate using chemiluminescence immunoassay. The antibody binding is expressed as mean ± SD in relative light
units measured in 100 milliseconds (RLU/100ms). Plasma antibody levels as box-whisker plots represent 25%, 50%
and 75% of the distribution, where the whiskers represent 10% and 90% distribution of the values and the cross
represents the maximum and minimum range. The solid diamonds are the mean values. P-values less than 0.05 are
regarded as statistically significant (nonparametric Mann-Whitney U test).  p< 0.05,  p< 0.001.
https://doi.org/10.1371/journal.pone.0191216.g003
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plasma IgA levels to Rgp44 and high IgG levels to Pg-LPS had more atherosclerotic lipid
deposits compared to those with low antibody levels. There was a significant positive
Fig 4. Mouse plasma IgA levels to Rgp44, Pg, PCho, and Pg-LPS before immunization (week 0), before HFD
(week 13), and at the end of the study (week 39) in LDLR-/- mice immunized with saline, Rgp44, and heat-
inactivated Pg. Each mouse plasma sample was measured in triplicate using chemiluminescence immunoassay.
The IgA antibody binding is expressed as mean ± SD in relative light units measured in 100 milliseconds (RLU/
100ms). P-values less than 0.05 are regarded as statistically significant (nonparametric Mann-Whitney U test).
 p < 0.05,  p < 0.01,  p < 0.001.
https://doi.org/10.1371/journal.pone.0191216.g004
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Fig 5. Association of mouse plasma IgA and IgG levels with atherosclerotic plaque area in LDLR-/- mice immunized
with saline, Rgp44, and heat-inactivated Pg. Plasma IgA and IgG to Rgp44 and Pg-LPS as well as plasma IgA to PCho
were determined in triplicate by chemiluminescence immunoassay. The antibody level is expressed as relative light units
measured in 100 milliseconds (RLU/100ms). Associations are determined using Spearman rank correlation coefficient
(ρ). P-values (p) less than 0.05 are regarded as statistically significant.
https://doi.org/10.1371/journal.pone.0191216.g005
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association between the plaque area and plasma IgA levels to Rgp44 (ρ = 0.764, p = 0.006, Fig
5) and plasma IgG levels to Pg-LPS (ρ = 0.773, p = 0.005, Fig 5) in Pg-immunized mice. Plasma
IgG and IgM levels to Rgp44, Pg-bacteria, PCho, and OxLDL were not associated with the ath-
erosclerotic lipid deposits in any of the groups (data not shown). In addition, plasma IgA levels
to Pg-LPS and PCho were not associated with the amount of atherosclerosis lipid deposits in
any of the groups (Fig 5).
Rgp44-immunized mice with lower plasma IL-1α levels had less
atherosclerotic lesions
To further investigate inflammatory responses to Rgp44 and Pg, plasma interleukin levels were
measured. Mouse plasma IL-5, IL-6, and IL-10 levels (pg/mL) at three different time points
were shown (Fig 6A, 6C and 6E). Plasma IL-5, IL-6, and IL-10 levels increased in all immuni-
zation groups. IL-5 and IL-10 levels were also significantly higher in the Pg group (Fig 6B and
6F) than in the Rgp44 and saline groups at the end of the study (week 39). In addition, IL-6
level in Pg-immunized mice was significantly higher than in Rgp44 mice (Fig 6D). No signifi-
cant difference in plasma interleukin levels was observed between the Rgp44 and saline immu-
nization groups.
LDLR-/- mice immunized with Rgp44 and with less atherosclerosis had lower IL-1α levels
than those with extensive atherosclerosis. There was a significant positive association between
plaque area and plasma IL-1α levels (ρ = 0.629, p = 0.028, Fig 7). The other measured plasma
interleukins (IL-2, IL-5, IL-6, IL-10, IL-13, IL-21, IL-22, IL-27, INF-γ or TNF-α) were all simi-
lar in Rgp44-immunized mice compared to the saline group. None of them associated with the
plaque area in Rgp44-immunized mice (Fig 7, S4 Fig). LDLR-/- mice immunized with Pg had
increased plasma IL-5, IL-10, IL-21, IL-22, INF-γ and TNF-α levels compared to the saline
control (Fig 7, S4 Fig). Pg-immunized mice with extensive atherosclerosis had lower IL-5, IL-
10 and IL-22 levels than those with less atherosclerosis. A significant negative association was
observed (Fig 7) between plaque area and IL-5 (ρ = - 0.609, p = 0.047), or IL-10 (ρ = - 0.636,
p = 0.035), or IL-22 (ρ = - 0.609, p = 0.047). None of the other measured interleukin levels (IL-
1α, IL-2, IL-6, IL-13, IL-21, IL-27, INF-γ or TNF-α) associated with the plaque area in Pg-
immunized mice (Fig 7, S4 Fig). Saline-immunized mice showed no association between the
atherosclerotic lipid deposits and any of the plasma interleukin levels tested (Fig 7, S4 Fig).
Discussion
The present study investigated in detail the immune responses to Rgp44, a gingipain A hemag-
glutinin domain of Porphyromonas gingivalis (Pg) which is one of the most important patho-
genic bacteria in chronic periodontitis. Immunization with Rgp44 led to IgM but not IgG
production against MAA-LDL, CuOx-LDL, and PCho. In other studies, these kinds of
humoral changes have previously been linked to atherosclerosis. A significant negative associa-
tion was observed between atherosclerotic lesion and plasma IgA to Rgp44 in Rgp44 immu-
nized mice, indicating further an anti-atherogenic effect of the immunization.
OxLDL contains various types of immunogenic epitopes derived from modified proteins
and lipids. In recent years, the MAA epitope has gained more attention because it is a closely
related structure to MDA and is proposed to be one of the main epitopes after MDA modifica-
tion [4–7]. MAA adduct is known to be a significant target for human natural antibodies in
newborns and premature babies [5]. MAA-specific Fab antibodies have been cloned from a
phage display library constructed from umbilical cord blood lymphocytes. They recognize
apoptotic cells and may play a role in immunomodulation of atherogenesis [5]. Furthermore,
saliva samples from healthy humans have recently been reported to contain IgA antibodies to
Immune response to Rgp44 and Pg in low-density lipoprotein receptor-deficient mice
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MAA-LDL which cross-react with the periodontal pathogen Porphyromonas gingivalis (Pg)
[25], although the autoantibody levels to OxLDL in saliva are not associated with the autoanti-
body levels to OxLDL in plasma. More recently, an ELISA (enzyme-linked immunosorbent
assay) with purified MAA as antigen has been established, offering a specific and sensitive
detection of anti-MAA antibody titer at a very early stage of atherosclerosis [6].
The role of plasma autoantibodies to OxLDL in cardiovascular disease (CVD) remains
debated. Growing evidence indicates that high levels of IgM antibodies to OxLDL are inversely
associated with cardiovascular disease, suggesting a protective role for IgM antibodies [5,9,18–
Fig 6. Mouse plasma IL-5, IL-6, and IL-10 cytokine levels in LDLR-/- mice immunized with saline, Rgp44, and
heat-inactivated Pg. Mouse plasma cytokine levels were determined with cytometric bead assay (CBA) from each
mouse plasma sample and expressed as picograms per milliliter plasma (pg/mL). Samples at week 0 and week 13 were
pooled together within each immunization group. At week 39 the plasma samples were not pooled, but measured as
individuals. (A, C, E) Plasma cytokine levels at different time points within immunization groups (mean value). (B, D,
F) Plasma cytokine levels at the end of the study (week 39) as box-whisker plots represent 25%, 50% and 75% of the
distribution, where the whiskers represent 10% and 90% distribution of the values and the cross represents the
maximum and minimum range. The solid diamonds are the mean values.  p< 0.05,  p< 0.01.
https://doi.org/10.1371/journal.pone.0191216.g006
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20]. It is not yet fully understood by which mechanisms the IgM antibodies confer atheropro-
tection. One explanation is that they bind to OxLDL and inhibit its uptake by macrophage
scavenger receptors [26]. In this study, significant elevation of plasma IgM antibody levels, but
not IgG levels, to MAA-LDL, CuOx-LDL, and PCho was observed in Rgp44- and Pg-immu-
nized mice. The results suggest that the induced IgM antibodies to OxLDL may attenuate the
proatherogenic effect of oxidative agents, advocating atheroprotective roles for both Rgp44
and Pg immunizations. It has not yet been fully understood whether the molecular mimicry
between the periodontal pathogens and the oxidation-specific epitopes is involved in the
Fig 7. Association of mouse plasma IL-1α, IL-5, IL-10, and IL-22 cytokine levels with atherosclerotic plaque area in
LDLR-/- mice immunized with saline, Rgp44, and heat-inactivated Pg. Mouse plasma cytokine levels were determined
with cytometric bead assay (CBA) from each mouse plasma sample. They are expressed as picograms per milliliter plasma
(pg/mL). Associations are determined using Spearman rank correlation coefficient (ρ). P-values (p) less than 0.05 are
regarded as statistically significant.
https://doi.org/10.1371/journal.pone.0191216.g007
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pathogenesis of atherosclerosis. It is widely accepted that the antibodies raised against one
antigen may cross-react with another if they share sufficiently similar structures. A natural
mouse monoclonal IgM antibody (Aa_Mab) cloned against MAA-LDL has been shown to rec-
ognize epitopes from chaperonin 60 (heat shock protein 60) of Aggregatibacter actinomycetem-
comitans (Aa), another key microbe in periodontitis [27,28]. Structural biology studies may
provide more direct evidence to confirm whether Pg arginine-specific gingipain A adhesion/
hemagglutinin domain (Rgp44) possesses a similar structure to MAA adducts. Our data sug-
gest that Rgp44/Pg bacteria and MAA adducts may share cross-reactive epitopes that induce
the IgM antibody production which in turn affect the progression of atherosclerosis.
Little is known about the role of IgA in atherosclerosis. IgA antibodies in cardiovascular
disease have been shown to represent a sign of recent or repeated or persistent infection; how-
ever, the significance is not yet known [29–32]. High IgA antibody level to Pg predicts myocar-
dial infarction and stroke independently of established CVD risk factors [29,33]. In the present
study, a significant negative association between the plaque area and plasma IgA to Rgp44 was
demonstrated, providing further evidence that IgA antibodies may play an important role in
atherogenesis and indicating that the immunization with Rgp44 may exert a protective effect
via regulation of plasma IgA antibody levels against the protease secreted by Pg. Plasma IgA
levels to PCho were considerably elevated in Rgp44-immunized mice; however, they were not
found to be associated with the size of atherosclerosis lipid deposits. In contrast to Rgp44
immunization, IgA levels to MAA-LDL and to Pg lipopolysaccharides (Pg-LPS) were increased
in Pg-immunized mice. Likewise, in this immunization group, a positive correlation was
observed between the plaque area and plasma IgA antibody levels to Rgp44, which implies that
different immunogenic molecules in Pg may act differently from Rgp44 in regard of their role
in the development of atherosclerosis. IgA titers to Rgp44 and to Pg in both Rgp44- and Pg-
immunized mice were significantly higher than those of saline control, suggesting that IgA to
Rgp44 could be a surrogate marker of immunization in Pg-immunized mice. The antibody
responses of Rgp44- and Pg-immunized groups resemble each other closely, providing clues
that the Rgp44 domain may be important for the atheroprotective effect of Pg immunization.
Further studies are needed to determine the possible correlation between IgA antibody and
atherosclerosis.
We and others have previously demonstrated that immunization with killed whole Pg is
atheroprotective in mouse models [21,34]. In this study, LDLR-/- mice immunized with Rgp44
or Pg did not have significantly less atherosclerosis than controls. However, the atherosclerotic
plaque areas in Rgp44- and Pg-immunized mice, but not in control mice, were associated with
several immune biomarkers, e.g. plasma IgA to Rgp44, plasma IgG to Pg-LPS, as well as plasma
IL-1α, IL-5, and IL-10 levels. We have previously immunized LDLR-/- mice with heat-inacti-
vated Pg and PBS [21]. In the current study, the same mouse strain was selected, but the dura-
tion of immunization and HFD was prolonged for 5 and 8 weeks, respectively. The area of
aortic plaque in the en face analysis of the current study was over two-fold more than in our
previous study [21]. Longer HFD may influence the progression of atherosclerosis and could
thus have affected the plaque formation, confounding the protective role of Rgp44 or Pg
immunization.
Different cytokines are expressed in atherosclerotic lesions. There is a balance between pro-
and anti-inflammatory cytokines and the balance is crucial for lesion development [35,36]. In
this study, positive association with atherosclerotic plaque area was only seen in IL-1α among
the cytokines measured in Rgp44-immunized mice. The phenomenon was not observed in
saline- and Pg-immunized mice, revealing a different orchestration action of cytokines
between Rgp44 and Pg immunizations. IL-1α mediates the early phases of sterile inflammation
by rapidly initiating a cascade of inflammatory cytokines and chemokines, which plays a
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central role in the inflammation induced by apoptotic/necrotic cell death. However, the
amount of circulating IL-1α is generally very low, and rarely detected even in patients with
severe infections [37]. Reduced atherosclerosis has been reported in IL-1α-deficient mice [37].
Atherosclerotic lesions have long been associated with IL-1β [38]. The differential induction
and distinct roles of IL-1α and IL-1β in fat-induced vascular responses and atherosclerosis
have recently been highlighted [38]. Unexpectedly, the fatty acids elicit release of IL-1α but not
IL-1β, revealing a selective IL-1α-persistent pathway of vascular inflammation and pathology,
and suggesting a role of IL-1α in atherosclerosis. IL-5 has been suggested to play a role in pro-
tection against atherosclerosis in humans due to the stimulation of B1 cells and the production
of IgM antibodies to OxLDL [39–41]. IL-10 is an anti-inflammatory cytokine mainly produced
in macrophages in local atherosclerotic plaques [42]. Lack of IL-10 impacts on the develop-
ment of atherosclerosis in mice [43]. IL-10 also suppresses Pg-driven inflammatory responses
of mucosal macrophages and may be a key mediator of endotoxin tolerance [44]. IL-22, a
member of the IL-10 cytokine family, has been demonstrated to play an important role in
mucosal immunity in protecting bacterial infections and regulating microbiota in the gut [45].
In our study, Pg-immunized mice had significantly higher IL-5, IL-10, and IL-22 titers than
the Rgp44- and saline-immunized mice. These cytokines also had a significant negative corre-
lation to the area of atherosclerotic plaque in Pg-immunized mice, in line with our previous
findings [21,22] and demonstrating an atheroprotective effect of the anti-inflammatory cyto-
kines. However, the atherogenic properties of IL-6 are controversial. The recombinant IL-6
aggravates atherosclerosis in apoE-/- mice [46] and inhibition of IL-6 trans-signaling reduces
atherosclerosis [47] whereas other studies show atheroprotective properties of IL-6 [48,49]. In
our study, Pg-immunized mice had the highest concentration of IL-6 when compared to the
other immunization groups. Atheroprotective properties of IL-6 were not observed and there
was no correlation between IL-6 and total plaque area in any of the immunization groups.
Overall, it is intriguing that IL-1α may exert effect on progression of atherosclerosis in
Rgp44-immunized mice whereas the anti-inflammatory cytokines IL-5 and IL-10 are crucial
for possible atheroprotection in Pg-immunized mice. Pg immunization seems to play a more
potent role in mediating and regulating cellular inflammatory responses.
Taken together, our data suggest an atheroprotective effect for Rgp44 and Pg immuniza-
tions. Rgp44/Pg and OxLDL, especially MAA adducts, may share cross-reactive epitopes
which allow a prompt IgM antibody response leading to reduced risk of atherosclerosis. Both
Rgp44 and Pg immunizations may also provide atheroprotection via modulation of pro- and
anti-inflammatory cytokines levels. This immunization study promotes our understanding of
the immune responses related to the development of atherosclerosis, and may also contribute
to refining the current approaches aiming to regulate immune responses and inflammatory/
anti-inflammatory processes in the disease.
Supporting information
S1 Fig. Experimental timeline for immunizations, blood sample collections, and diet
changes. LDLR-/- mice were immunized with phosphate buffered saline (Saline, n = 14), or
Porphyhromonas gingivalis arginine-specific gingipain A adhesion/hemagglutinin domain
(Rgp44, n = 13), or heat-inactivated whole Pg bacteria (Pg, n = 13). No adjuvants were used
with the immunogens. Mice were fed normal chow diet for 13 weeks followed by HFD for 27
weeks. At the end of the study, the mice were sacrificed and atherosclerosis was quantified by
en face analysis.
(TIF)
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S2 Fig. Mouse plasma IgG and IgM antibody levels to Rgp44 and to heat-inactivated whole
Pg bacteria before immunization (week 0) and at the end of the study (week 39). Each
mouse plasma sample was measured in triplicate using chemiluminescence immunoassay. The
antibody binding is expressed as mean ± SD in relative light units measured in 100 millisec-
onds (RLU/100ms). Plasma antibody levels as box-whisker plots represent 25%, 50% and 75%
of the distribution, where the whiskers represent 10% and 90% distribution of the values and
the cross represents the maximum and minimum range. The solid diamonds are the mean val-
ues. P-values less than 0.05 are regarded as statistically significant (nonparametric Mann-
Whitney U test).  p< 0.05,  p< 0.01,  p< 0.001.
(TIF)
S3 Fig. Quantification of atherosclerosis in LDLR-/- mice immunized with saline, Rgp44,
and heat-inactivated Pg. A) The extent of atherosclerotic plaque development was determined
after HFD at the end of the study (week 39) by en face analysis of the aortas. Sudan IV-stained
aortic plaque areas were measured. Lesion sizes at the aortas are expressed as percentage of pla-
que area per total area of aorta. The aortic plaque areas as box-whisker plots represent 25%,
50% and 75% of the distribution, where the whiskers represent 10% and 90% distribution of
the values and the cross represents the maximum and minimum range. The solid diamonds
are the mean values. P-values less than 0.05 are regarded as statistically significant (nonpara-
metric Mann-Whitney U test). ns: not significant. B) Representative pictures of the stained
aortas are shown for each group.
(TIF)
S4 Fig. Association of mouse plasma IL-2, IL-6, IL-13, IL-21, IL-27, INF-γ, and TNF-α
cytokine levels with atherosclerotic plaque area in LDLR-/- mice immunized with saline,
Rgp44, and heat-inactivated Pg. Mouse plasma cytokine levels were determined with cyto-
metric bead assay (CBA) from each mouse plasma sample. They are expressed as picograms
per milliliter plasma (pg/mL). Associations are determined using Spearman rank correlation
coefficient (ρ). P-values (p) less than 0.05 are regarded as statistically significant.
(TIF)
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